Olaparib Effective in BRCA2-Altered Biochemical Recurrence Post-Prostatectomy in Phase 2 Study - Catherine Handy Marshall
Catherine Marshall
Cathy Marshall discusses a non-randomized clinical trial evaluating olaparib without androgen deprivation therapy for high-risk biochemically recurrent prostate cancer following prostatectomy.
Exercise Benefits In Prostate Cancer Active Surveillance - Dong-Woo Kang
Dong-Woo Kang
Dong-Woo Kang joins Andrea Miyahira to discuss his team’s research on high-intensity interval training in prostate cancer patients undergoing active surveillance.
